Reposted by Leo SchellerNature Chemical Biology @natchembio.nature.com · 25/09/2026Our October issue is live! www.nature.com/nchembio/vol... Inspired by the phases of the moon, the cover artwork uses light and darkness to depict pharmacological control of chimeric antigen receptor (CAR) T cells 031
Leo Scheller @leoscheller.bsky.social · 29/09/2026Beautiful! Grateful for having coauthors with additional talents to science. Congratulations on making the cover, amazing job 🙌 001
Reposted by Leo SchellerKhmelinskaia Lab @akhmelinlab.bsky.social · 05/07/2026De novo designed oligomers that respond to copper, small molecules, and phosphorylation... Using a single design strategy? 🧬⚙️ 🎉 Excited to share our new bioRxiv preprint—a collaboration between the Khmelinskaia, Correia, Schoeder and a Tinnefeld labs! www.biorxiv.org/content/10.6...biorxiv.orgA generalizable interface-seeded framework for de novo design of functional oligomersProtein oligomers are ubiquitous in biological systems and essential for function. However, the de novo design of oligomers that controllably assemble in response to exogenous stimuli remains challeng... 2259
Reposted by Leo SchellerNicholas Southern @neuroscinikolai.bsky.social · 05/07/2026New preprint! We used protein domain insertion to tighten the editing window of the TadA8e adenine base editor. Bulky domain insertions concentrated editing around position A5, maintained robust on-target activity, and reduced Cas-independent off-target editing. 🧬 doi.org/10.64898/202...biorxiv.orgDomain Insertion Improves the Precision of a CRISPR Adenine Base EditorAdenine base editors (ABEs) enable efficient A:T to G:C conversion, but their broad activity windows frequently cause unintended bystander edits. We hypothesized that insertion of a bulky, inert prote... 2126
Reposted by Leo SchellerMartin Pacesa @martinpacesa.bsky.social · 15/06/2026Our lab website is finally online! pacesalab.com You can find information about our research, publications, and on-going developments in the lab. 1508
Reposted by Leo SchellerNature @nature.com · 18/04/2026A system of protein binders directs energy-generating organelles to targeted cells, potentially improving ways to treat mitochondrial dysfunction go.nature.com/42bk2wXgo.nature.comTherapeutic mitochondria transplants made more efficient with targeting toolA system of protein binders directs energy-generating organelles to targeted cells, potentially improving ways to treat mitochondrial dysfunction. 0479
Reposted by Leo SchellerUCSF Helen Diller Family Comprehensive Cancer Center @ucsfcancer.bsky.social · 07/04/2026DROP-CARs: Engineering Reversible, Drug-Controlled CAR T Cell Activity with a Clinically Approved Small Molecule | Wendell Lim @ucsanfrancisco.bsky.social Adam Stevens @upenn.edu via @theaacr.bsky.social url: aacrjournals.org/cancerres/ar...aacrjournals.orgDROP-CARs: Engineering Reversible, Drug-Controlled CAR T Cell Activity with a Clinically Approved Small MoleculeAbstract. A major limitation in applying chimeric antigen receptor (CAR) T cells to solid tumors is toxicity in healthy tissues caused by a lack of tumor-specific targets. A promising strategy to over... 052
Reposted by Leo SchellerNature Chemical Biology @natchembio.nature.com · 24/02/2026Drug-controlled DROP-CARs enable reversible extracellular control of CAR T cell function via human-derived protein switches that modulate cell-cell interactions and support dual-antigen targeting as well as logic-gated signaling www.nature.com/articles/s41...nature.comDrug-controlled CAR T cells through the regulation of cell–cell interactions - Nature Chemical BiologyDrug-controlled DROP-CARs enable reversible extracellular control of CAR T cell function via human-derived protein switches that modulate cell–cell interactions and support dual-antigen targeting as w... 031
Reposted by Leo SchellerBIOspektrum @claudialudy.bsky.social · 04/03/2026Manchmal greifen CAR-T-Zellen gesundes Gewebe an und verursachen Nebenwirkungen. Ein internationales Forscherteam hat nun ein System entwickelt, um die Bindung von T-Zellen an andere Zellen durch ein zugelassenes Medikament zu kontrollieren. doi.org/10.1038/s415... Bild: Copyright: Leo Scheller 021
Reposted by Leo SchellerEMBL-EBI @ebi.embl.org · 16/03/2026You asked, we listened. Millions of AI-predicted protein complex structures are now available in the #AlphaFold Database. This spans homodimers from 20 of the most studied species, including humans, as well as the World Health Organization’s priority pathogens list. www.ebi.ac.uk/about/news/t... 816087
Reposted by Leo SchellerKieran Didi @kdidi.bsky.social · 17/03/2026📢 We’re launching Proteina-Complexa — and after the Jensen keynote mention, we definitely had to post this thread now ;) Atomistic binder design with generative pretraining + test-time compute, plus large-scale wet-lab validation. Project page: research.nvidia.com/labs/genair/... 🧵 1/n 13716
Reposted by Leo SchellerGerman Association for Synthetic Biology (GASB) e.V @gasb-synbio.bsky.social · 11/03/2026High throughput data are more important than ever💻. On this note, Markus Jeschek from EPFL, shows us how translation initiation can be engineered, utilizing mRNA folding or tRNA interactions to tune protein production📈! 051
Reposted by Leo SchellerBenjamin Friedrich @friedrich-group.bsky.social · 03/03/2026Looking for a theory partner for an #HFSP project? #morphogenesis in cells and tissues, #chemotaxis, #cilia? Feel free to reach out! Deadline for letters of intent 26.03.2026. physics-of-life.tu-dresden.de/team/pol-gro...physics-of-life.tu-dresden.dePoL – Physics of Life | Team | PoL Groups | Benjamin FriedrichPhysics of Life: Discover new paradigms for understanding life and deepen our knowledge of living biological matter 033
Reposted by Leo SchellerInformationsdienst Wissenschaft - idw @idw-online.de · 03/03/2026Wirkstoff-gesteuerte CAR-T-Zellen: Ein neuer Sicherheitsmechanismus für die Krebsimmuntherapie Die chimäre Antigenrezeptor-(CAR)-T-Zelltherapie basiert auf gentechnisch veränderten Immunzellen, die Krebszellen aufspüren und zerstören. Manch... weiterlesen 032
Reposted by Leo SchellerNeva Caliskan @caliskanlab.bsky.social · 06/03/2026We are looking for RNA enthusiasts to join us at the @uniregensburg.bsky.social as a junior group leader! Our university offer excellent infrastructure and collaboration opportunities for ground breaking RNA research. Please RT @jrrnascientists.bsky.social @rnasociety.bsky.social 0119
Leo Scheller @leoscheller.bsky.social · 03/03/2026The core idea of this project was that we wanted a new CAR safety switch that works with minimally altered human proteins, an approved drug, and by breaking or inhibiting cell-cell contact. After a lot of optimization, this worked pretty well! www.nature.com/articles/s41...nature.comDrug-controlled CAR T cells through the regulation of cell–cell interactions - Nature Chemical BiologyDrug-controlled DROP-CARs enable reversible extracellular control of CAR T cell function via human-derived protein switches that modulate cell–cell interactions and support dual-antigen targeting as w... 150
Reposted by Leo SchellerAmanda Moehring @flybehaviour.bsky.social · 13/02/2026Ooooh. Cool new paper on origins of life. A simple 45-nucleotide RNA molecule that can perfectly copy itself. www.science.org/doi/10.1126/...science.orgA small polymerase ribozyme that can synthesize itself and its complementary strandThe emergence of a chemical system capable of self-replication and evolution is a critical event in the origin of life. RNA polymerase ribozymes can replicate RNA, but their large size and structural ... 014358
Reposted by Leo SchellerPaul & Virginie - Centriole Lab @centriolelab.bsky.social · 10/12/2025We’re excited to announce the opening of the Geneva Expansion Microscopy Facility (GenExM)! GenExM is a full-service U-ExM platform (U-ExM, Cryo-ExM, iU-ExM), delivering nanoscale imaging. Led by Dr. Olivier Mercey, GenExM welcomes academic & industrial collaborations. 👉 www.unige.ch/genexm/ 214235
Reposted by Leo SchellerKerstin Göpfrich @kgoepfrich.bsky.social · 09/12/2025We are recruiting a tenure track professor in the broader area of molecular biology @zmbh.uni-heidelberg.de at Heidelberg University! www.nature.com/naturecareer... Please share and apply!nature.comTenure Track Professorship (W1 with Tenure Track to W3) in “Molecular Biology" (f/m/d) - Heidelberg job with Universität Heidelberg | 12850668The Center for Molecular Biology of Heidelberg University (ZMBH) and the Faculty of Biosciences invite applications for a Tenure Track Professors... 06958
Reposted by Leo SchellerSimon Dürr @handle.invalid · 01/10/2025Cool work to design phospho-tyrosine binder by the Baker lab. They show it works but success rate is low (<0.1%) and binders are not super strong (>500nM, likely related to cost of desolvating the phosphate) . www.biorxiv.org/content/10.1... 1165
Reposted by Leo SchellerAdrian Woolfson @adrianwoolfson.bsky.social · 04/10/2025A computationally-designed ‘random walker’ protein with tiny feet can walk back and forth across a micrometer-long fiber share.google/3gzWosAVOeAh...share.googleDe-novo design of a random protein walkerMolecular machines hold great potential. Design of static monomeric and oligomeric protein structures has advanced tremendously, but few dynamic protein systems have been designed. Here we present the... 031
Reposted by Leo SchellerNature @nature.com · 01/09/2025Nature research paper: One-shot design of functional protein binders with BindCraft go.nature.com/46bhOAvgo.nature.comOne-shot design of functional protein binders with BindCraft - NatureBindCraft, an open-source, automated pipeline for de novo protein binder design with experimental success rates of 10–100%, leverages AlphaFold2 weights to generate binders with nanomolar affinity without the need for high-throughput screening. 15020
Reposted by Leo SchellerMartin Pacesa @martinpacesa.bsky.social · 27/08/2025Exciting to see our protein binder design pipeline BindCraft published in its final form in @Nature ! This has been an amazing collaborative effort with Lennart, Christian, @sokrypton.org, Bruno and many other amazing lab members and collaborators. www.nature.com/articles/s41... 14305109
Reposted by Leo SchellerMartin Pacesa @martinpacesa.bsky.social · 25/07/2025I am super excited to announce that I will be starting my lab at the Department of Pharmacology of the University of Zurich in Switzerland next year! 2321839
Reposted by Leo SchellerMartin Pacesa @martinpacesa.bsky.social · 12/07/2025We (meaning Aswin and Stan www.biorxiv.org/content/10.1...) found this jumbophage protein homologue of PhiKZ_124 that activates Avast5 and we solved a 2.1A cryoEM structure of but we have no idea what it does. Let me know it you got some idea. www.rcsb.org/structure/9RP3biorxiv.orgMolecular basis for anti-jumbo phage immunity by AVAST Type 5Jumbo phages protect their genomes from DNA-sensing bacterial defense systems by enclosing them within vesicles and nucleus-like compartments. Very little is known about defense systems specialized to... 0286
Leo Scheller @leoscheller.bsky.social · 08/07/2025My highest recommendation! Working with Martin is the ideal entry point into protein design. 112
Reposted by Leo SchellerbioRxiv Synthetic Biology @biorxiv-synthbio.bsky.social · 14/06/2025Humanized Caffeine-Inducible Systems for Controlling Cellular Functions www.biorxiv.org/content/10.1101/202… 075
Reposted by Leo SchellerbioRxiv Synthetic Biology @biorxiv-synthbio.bsky.social · 14/06/2025Caffeine-regulated molecular switches for functional control of CAR T cells in vivo www.biorxiv.org/content/10.1101/202… 072
Reposted by Leo SchellerGregor Hagelueken @gha14.bsky.social · 18/05/2025Happy to share our first foray into the world of AI-based #ProteinDesign. www.biorxiv.org/content/10.1...biorxiv.orgDevelopment of AI-designed protein binders for detection and targeting of cancer cell surface proteinsArtificial intelligence (AI)-based protein design opens new avenues for the rapid generation of new research tools and therapeutics, but experimental validation lags behind the computational design th... 154
Reposted by Leo SchellerChise @sailorrooscout.bsky.social · 16/05/2025THIS IS HUGE! TWO Phase I HIV vaccine clinical trials have demonstrated that a stepwise mRNA-based vaccination strategy can SUCCESSFULLY activate AND advance immune responses toward producing broadly neutralizing antibodies (bnAbs), a CRITICAL milestone in HIV prevention. Let’s talk about that! 🧪🧵⬇️ 3238991139
Reposted by Leo SchellerDiego del Alamo @delalamo.xyz · 15/05/2025"Adapting ProteinMPNN for antibody design without retraining" Our several-years-old fix to ProteinMPNN's tendency to make weird antibody CDR sequences is finally preprintedbiorxiv.orgAdapting ProteinMPNN for antibody design without retrainingThe neural network ProteinMPNN designs protein sequences capable of folding into predefined tertiary structures and quaternary assemblies. It has become widely used due to its high success rates when ... 14614
Reposted by Leo SchellerRoger Castells @rcastellsg.bsky.social · 07/05/2025Hi everyone! I’m a #NewPI just starting my lab and would love to hear your advice on lab management and building the lab culture. Any tips, lessons learned, or resources you’ve found helpful are very welcome! Feel free to reply, message me, or email me at rcastellsg(at)cnio.es thanks a lot!! 🤗media.tenor.coma cat is sitting in front of a laptop computer asking for adviceALT: a cat is sitting in front of a laptop computer asking for advice 183819
Reposted by Leo SchellerErik van Nimwegen @erikvannimwegen.bsky.social · 09/05/2025Here it is! Bonsai. Now there is really no more excuse for using t-SNE/UMAP. Bonsai not only makes cool pictures of your data. It actually rigorously preserves its structure. No tunable parameters. Incredible work by @dhdegroot.bsky.social. I'm so excited about this! www.biorxiv.org/content/10.1...biorxiv.orgBonsai: Tree representations for distortion-free visualization and exploratory analysis of single-cell omics dataSingle-cell omics methods promise to revolutionize our understanding of gene regulatory processes during cell differentiation, but analysis of such data continues to pose a major challenge. Apart from... 9335108
Reposted by Leo SchellerDominik Niopek @dominikniopek.bsky.social · 05/05/2025www.biorxiv.org/content/10.1...biorxiv.orgModular Engineering of Thermo-Responsive Allosteric ProteinsThermogenetics enables non-invasive spatiotemporal control over protein activity in living cells and tissues, yet its applications have largely been restricted to transcriptional regulation and membra... 0147
Reposted by Leo SchellerMax Fürst @maxfus.bsky.social · 03/05/2025If u ever had to depict proteins as schematics in papers, u know the dilemma: how to create a pretty “blob”? If structure ends up big & central, u’ll render it with PyMol et al, but for a truly schematic depiction u want a biorender-style icon, but for YOUR protein. Think I’ve finally found a way. 719246
Reposted by Leo Schellerross @rosscloney.bsky.social · 02/05/2025Programmable protein stabilization with language model-derived peptide guides www.nature.com/articles/s41...nature.comProgrammable protein stabilization with language model-derived peptide guides - Nature CommunicationsDysregulated protein degradation drives diseases like cancer. Here, authors use protein language models to design target-binding peptides, which are subsequently attached to the catalytic domain of th... 121
Reposted by Leo SchellerAaron Ring @aaronmring.bsky.social · 29/04/2025You’ve heard of vibe coding—meet vibe protein design. Click, launch, and watch the binders roll in. That’s what we're unveiling with @ariaxbio.bsky.social today. 2175
Reposted by Leo SchellerMartin Steinegger 🇺🇦 @martinsteinegger.bsky.social · 27/04/2025AFESM: a metagenomic guide through the protein structure universe! We clustered 821M structures (AFDB&ESMatlas) into 5.12M groups; revealing biome-specific groups, only 1 new fold even after AlphaFold2 re-prediction & many novel domain combos. 🧵 🌐 afesm.foldseek.com 📄 www.biorxiv.org/content/10.1... 414170
Reposted by Leo SchellerJames Lingford @jameslingford.bsky.social · 28/04/2025Baker lab PyMOL config 👇 0112
Reposted by Leo SchellerMiha Modic @paraspeckle.bsky.social · 18/04/2025Thank you, Lennart! I'm very excited to join the newly founded Carl Zeiss Center for Synthetic Genomics and KIT with your lab nextdoor! Exciting times ahead! 162
Leo Scheller @leoscheller.bsky.social · 13/03/2025I’m looking for a BTA and a Postdoc to help set up the Structural Biochemistry group at the Leibniz Institute for Immunotherapy (LIT) in Regensburg 😀. We apply synthetic biology and protein design to address key challenges in immunotherapy. lit.eu/work-with-us/ #SynBio #ProteinDesign #Immunotherapylit.euWork With UsThe LIT welcomes individuals from all life paths and academic backgrounds. If you are passionate about science we could be the perfect home for you. 0104
Reposted by Leo SchellerAcademic Europe @academiceurope.bsky.social · 13/03/2025Job - Alert 🌱 ‼️ POSTDOCTORAL SCIENTIST (M/F/D) Deadline: 2025-04-06 Location: Germany, Regensburg, Bayern www.academiceurope.com/job/?id=7176 #hiring #Immunotherapy #Postdoc #LIT #syntheticbiology #proteindesignacademiceurope.comAcademic Europe - Postdoctoral scientist (m/f/d) 032
Reposted by Leo SchellerBrian Naughton @btnaughton.bsky.social · 08/03/2025new blogpost on protein binder design blog.booleanbiotech.com/protein-bind...blog.booleanbiotech.comBoolean Biotech 2184
Reposted by Leo SchellerMartin Pacesa @martinpacesa.bsky.social · 07/03/2025Hats off to all our american colleagues out there protesting in the streets today, scientific progress is the only way to a better future and no government should stand in the way of that ✊🏼 0244
Reposted by Leo SchellerRené Inckemann @reneinckemann.bsky.social · 05/03/2025@synbio4allafrica.bsky.social #PlantSynBio education project will enable local students to sequence a native plant species and gain hands-on research and data analysis skills. They’ve secured ~76% of their microgrant. Now they need our help to cross the finish line: experiment.com/projects/exp...experiment.comExploring African biodiversity with an open-source educational program in Plant Synthetic BiologyMuch of Africa's plants have not been studied. As a non-profit, SynBio4ALL aims to study plant biodiversity in combination with emerging technology to educate and inspire future African scientists. We... 01411
Leo Scheller @leoscheller.bsky.social · 26/02/2025I’m happy to share that I will join the LIT in Regensburg (lit.eu) as a Group Leader in Structural Biochemistry in May. We will combine synthetic biology and protein design to develop synthetic receptors and protein therapeutics to improve immunotherapy. Job openings will be available soon!lit.euLeibniz Institute for ImmunotherapyThe LIT develops innovative therapies for the treatment of cancer, autoimmunity, and chronic inflammation by reprogramming immune cells. 8265
Reposted by Leo SchellerKevin K. Yang 楊凱筌 @kevinkaichuang.bsky.social · 21/02/2025All-atom fixed backbone protein sequence design with FAMPNN @richardshuai.bsky.social Talal Widatalla @possuhuanglab.bsky.social @brianhie.bsky.social www.biorxiv.org/content/10.1... 0307
Reposted by Leo SchellercryoEM papers @cryoempapers.bsky.social · 21/02/2025De novo design of transmembrane fluorescence-activating proteins pubmed.ncbi.nlm.nih.gov/39972138/ #cryoEM 031